Safe Life Adds David Dennis to Board of Directors

SAN DIEGO, Feb. 10 /PRNewswire/ -- Safe Life Corp., an innovative antimicrobial company dedicated to developing novel technologies and products that help prevent the spread of infection and disease, today announced the appointment of David Dennis to its board of directors. An accomplished business veteran and venture capitalist with more than 25 years of experience managing finance and corporate strategy for a variety of companies, Dennis becomes the seventh member of Safe Life's distinguished board.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20091109/LA07319LOGO-b)

"I'm honored to join Safe Life's board of directors," said Dennis. "Safe Life is a company with a unique vision and a strong combination of experienced leadership and innovative product development. I am looking forward to helping the company achieve sustained growth and profitability as it continues developing cutting-edge, antimicrobial technologies and products."

Dennis is the founder of Los Angeles-based strategic consulting firm Evanston Advisors Inc. He previously served as managing director of Pacific Venture Group, a healthcare venture capital firm with a $210 million investment portfolio. During his career, Dennis also has held executive management positions at companies such as Tenet Healthcare Inc.; Donaldson, Lufkin & Jenrette Securities, Inc.; and Merrill Lynch Inc. In addition, he spent 15 years on the board of directors at Westwood One, Inc., most recently as chairman of the company's strategic review committee.

"We are very pleased to add someone with David's knowledge and breadth of experience to our board," said Richard Jaffe, chairman and CEO of Safe Life. "David's strategic input has been critical to the success of some of the most influential companies in America, and we believe he will play a key role in helping Safe Life bring its revolutionary technologies and products to the marketplace."

Dennis holds a bachelor's degree in economics and finance from San Diego State University and a master's in business administration in finance and corporate strategy from the University of California, Los Angeles. He spent four years in the U.S. Air Force, including a tour of duty in Vietnam in 1969, and three years in the Defense Attache Office at the American Embassy in Lisbon, Portugal. He was awarded a Bronze Star Medal, Joint Service Commendation Medal, and Air Force Commendation Medal in recognition of his service in the U.S. military.

About Safe Life

Safe Life Corp. is a company dedicated to developing novel antimicrobial technologies and products that help prevent the spread of infection and disease. Founded in 2006, at which time Triosyn Corp. became a wholly owned subsidiary, the company has developed a family of next-generation, NIOSH-certified respirators, including the Safe Life® A400 Series N95 respirator with antimicrobial protection and the Safe Life® T5000 Series P95 respirator with antimicrobial protection. Safe Life has more than 100 patents and patents pending. The Safe Life™ antimicrobial is an EPA-registered, solid-state antimicrobial that successfully harnesses the power of iodine, which has a nearly 200-year track record for being effective against a broad spectrum of microorganisms. Safe Life has garnered regulatory approvals, licenses, clearances and certifications from the Environmental Protection Agency (EPA), Food & Drug Administration (FDA), National Institute for Occupational Safety and Health (NIOSH), INSPEC (EU) and Health Canada. Headquartered in San Diego, Safe Life has manufacturing facilities and operations in Williston, Vt., Mirabel QC, Canada and Ipoh, Malaysia. For more information, visit www.safelifecorp.com.

SOURCE Safe Life Corp.